Nguyen Huong Q, Jumaan Aisha O, Seward Jane F
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
N Engl J Med. 2005 Feb 3;352(5):450-8. doi: 10.1056/NEJMoa042271.
Varicella disease has been preventable in the United States since 1995. Starting in 1999, active and passive surveillance data showed sharp decreases in varicella disease. We reviewed national death records to assess the effect of the vaccination program on mortality associated with varicella.
Data on deaths for which varicella was listed as an underlying or contributing cause were obtained from National Center for Health Statistics Multiple Cause-of-Death Mortality Data for 1990 through 2001. We calculated the numbers and rates of death due to varicella according to age, sex, race, ethnic background, and birthplace.
The rate of death due to varicella fluctuated from 1990 through 1998 and then declined sharply. For the interval from 1990 through 1994, the average number of varicella-related deaths was 145 per year (varicella was listed as the underlying cause in 105 deaths and as a contributing cause in 40); it then declined to 66 per year during 1999 through 2001. For deaths for which varicella was listed as the underlying cause, age-adjusted mortality rates dropped by 66 percent, from an average of 0.41 death per 1 million population during 1990 through 1994 to 0.14 during 1999 through 2001 (P<0.001). This decline was observed in all age groups under 50 years, with the greatest reduction (92 percent) among children 1 to 4 years of age. In addition, by the period from 1999 through 2001, the average rates of mortality due to varicella among all racial and ethnic groups were below 0.15 per 1 million population, as compared with rates ranging from 0.37 per 1 million for whites to 0.66 per 1 million for other races in the period from 1990 through 1994.
The program of universal childhood vaccination against varicella in the United States has resulted in a sharp decline in the rate of death due to varicella.
自1995年起,水痘疾病在美国已可预防。从1999年开始,主动和被动监测数据显示水痘疾病大幅减少。我们查阅了国家死亡记录,以评估疫苗接种计划对水痘相关死亡率的影响。
从国家卫生统计中心获取1990年至2001年多死因死亡率数据中,水痘被列为根本或促成死因的死亡数据。我们根据年龄、性别、种族、族裔背景和出生地计算了水痘导致的死亡人数和死亡率。
1990年至1998年,水痘导致的死亡率波动,随后急剧下降。1990年至1994年期间,水痘相关死亡的年平均人数为145人(其中105例水痘被列为根本死因,40例为促成死因);1999年至2001年期间降至每年66人。对于水痘被列为根本死因的死亡,年龄调整后的死亡率下降了66%,从1990年至1994年每百万人口平均0.41例死亡降至1999年至2001年的0.14例(P<0.001)。在50岁以下的所有年龄组中均观察到这种下降,其中1至4岁儿童下降幅度最大(92%)。此外,到1999年至2001年期间,所有种族和族裔群体中水痘导致的平均死亡率均低于每百万人口0.15例,而1990年至1994年期间,白人的死亡率为每百万人口0.37例,其他种族为每百万人口0.66例。
美国普遍的儿童水痘疫苗接种计划已导致水痘死亡率急剧下降。